Investigating the Effects of Cannabidiol on Social Anxiety Disorder
Status:
Not yet recruiting
Trial end date:
2025-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether a single-dose of Epidiolex (cannabidiol) is
associated with reduced psychological, physiological, and neuroimaging measures of anxiety in
people diagnosed with social anxiety disorder (SAD).